7-((1H-imidazol-4-yl)methyl)-5,6,7,8-tetrahydroquinoline
US7323477B2 · kind B2 · utility
9Cited by
5References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2006 |
| Grant date | Jan 29, 2008 |
| Priority date | — |
| Expiry date | Mar 20, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A compound having a structureor a pharmaceutically acceptable salt, or a prodrug thereof is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.